DapoxetineThird Party Manufacturing in India

Dapoxetine is a short-acting, potent selective serotonin reuptake inhibitor that delays ejaculation by enhancing serotonergic neurotransmission in the central nervous system. Unlike conventional SSRIs that are formulated for continuous daily dosing and take weeks to reach steady-state concentrations, dapoxetine is designed for on-demand administration prior to anticipated sexual activity. The drug acts by binding with high affinity to the serotonin transporter (SERT) on presynaptic nerve terminals, thereby blocking the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron. This inhibition increases the concentration and duration of serotonin in the synaptic space, allowing for enhanced activation of postsynaptic serotonin receptors, particularly the 5-HT1A and 5-HT2C receptor subtypes. The elevated serotonergic tone modulates the complex neural circuitry that controls the ejaculatory reflex, involving both supraspinal centres in the brainstem and the spinal ejaculatory generator. Specifically, dapoxetine increases the latency of the bulbospongiosus reflex and raises the ejaculatory threshold through its action on serotonergic neurons projecting from the raphe nuclei to the spinal cord. Dapoxetine is rapidly absorbed, reaching peak plasma concentrations within one to two hours, and has a short elimination half-life of approximately 1.5 hours, which makes it suitable for on-demand use with minimal accumulation and reduced risk of long-term SSRI-related side effects such as sexual dysfunction beyond its intended indication.

Therapeutic Uses

Dapoxetine is indicated for the treatment of premature ejaculation (PE) in men aged 18 to 64 years.

• Premature Ejaculation: The primary indication for dapoxetine is the on-demand treatment of all forms of premature ejaculation — lifelong, acquired, situational, and variable. Clinical trials have demonstrated a threefold to fourfold increase in intravaginal ejaculatory latency time compared to placebo.
• Lifelong PE: In patients who have experienced PE since their first sexual encounters, dapoxetine provides reliable and reproducible ejaculatory delay.
• Acquired PE: For men who develop PE later in life due to psychological factors, prostatic conditions, or thyroid dysfunction, dapoxetine offers effective symptom control alongside treatment of the underlying cause.

Why Manufacturers Choose Dapoxetine

Dapoxetine represents one of the highest-growth therapeutic segments in the Indian pharmaceutical market, driven by increasing awareness and destigmatisation of sexual health issues. India is the largest manufacturer of dapoxetine globally, with dozens of brands competing in the domestic market. The molecule is a favourite for PCD franchise models because of its high prescription volume, brand loyalty potential, and significant margin opportunities. It is often co-formulated or co-packaged with phosphodiesterase-5 inhibitors like sildenafil and tadalafil for combination therapy. The manufacturing process for the 30mg and 60mg tablet strengths is well-established, and the API is abundantly available from Indian manufacturers. Export demand from Asia, Africa, and Latin America is exceptionally high, making dapoxetine one of the most commercially attractive molecules for third-party pharmaceutical manufacturing in India.